Premium
L‐Dopa Treatment of Parkinson's Disease
Author(s) -
BAUER RAYMOND B.,
STEVENS CARL,
REVENO WILLIAM S.,
ROSENBAUM HERBERT
Publication year - 1982
Publication title -
journal of the american geriatrics society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.992
H-Index - 232
eISSN - 1532-5415
pISSN - 0002-8614
DOI - 10.1111/j.1532-5415.1982.tb05621.x
Subject(s) - medicine , asymptomatic , interim , levodopa , disease , parkinson's disease , pediatrics , physical therapy , surgery , archaeology , history
A ten‐year follow‐up study of parkinsonian patients treated with L‐dopa is presented. Originally 130 patients entered the study, and previous reports were presented in 1971 and 1973. This report concerns the 47 remaining patients now available for examination. The effectiveness of L‐dopa diminished over the ten‐year period, so that the disability states of these patients are now similar to those prevailing just before the study began ten years ago. Despite the decline, the interim improvement and the patients' relatively asymptomatic existence for part of the time confirm the effectiveness of L‐dopa therapy in the treatment of Parkinson's disease.